2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Atypical Teratoid
Exploring the enigmatic realm of Atypical Teratoid Rhabdoid Tumor (ATRT) within the context of cancer research unveils a landscape both challenging and promising. This malignancy, primarily assaulting the pediatric population, manifests its aggressiveness in the brain and spinal cord, warranting a nuanced investigative approach. Researchers meticulously dissect the genetic labyrinth of ATRT, aiming to decipher its unique mutations and molecular cascades. This genetic unraveling serves as the cornerstone for crafting bespoke therapeutic strategies, potentially revolutionizing treatment paradigms. In the crucible of scientific inquiry, immunotherapy emerges as a beacon of hope, alongside the tailored precision of targeted therapies, illuminating the path towards improved patient outcomes. The collaborative synergy among researchers and clinicians becomes the linchpin in navigating the complexities of ATRT, propelling us closer to effective interventions against this formidable adversary.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China